Literature DB >> 22247592

Amphiphilic Interpenetrating Networks for the Delivery of Hydrophobic, Low Molecular Weight Therapeutic Agents.

Cody A Schoener1, Heather N Hutson, Grace K Fletcher, Nicholas A Peppas.   

Abstract

To investigate the delivery of hydrophobic therapeutic agents, a novel class of interpenetrating networks (IPNs) were synthesized and composed of two networks: methacrylic acid grafted with poly(ethylene glycol) tethers, P(MAA-g-EG), and poly(n-butyl acrylate) (PBA). The hydrophilic P(MAA-g-EG) networks are pH-responsive hydrogels capable of triggered release of an encapsulated therapeutic agent, such as a low molecular weight drug or a protein, when it passes from the stomach (low pH) to upper small intestine (neutral pH). PBA is a hydrophobic homopolymer that can affect the IPN swelling behavior, the therapeutic agent loading efficiencies in IPNs, and solute release profiles from IPNs. In dynamic swelling conditions, IPNs had greater swelling ratios than P(MAA-g-EG), but in equilibrium swelling conditions the IPN swelling ratio decreased with increasing PBA content. Loading efficiencies of the model therapeutic agent fluorescein ranged from 21 - 44%. Release studies from neat P(MAA-g-EG) and the ensuing IPNs indicated that the transition from low pH (2.0) to neutral pH (7.0) triggered fluorescein release. Maximum fluorescein release depended on the structure and hydrophilicity of the carriers used in these studies.

Entities:  

Year:  2011        PMID: 22247592      PMCID: PMC3254099          DOI: 10.1021/ie201593h

Source DB:  PubMed          Journal:  Ind Eng Chem Res        ISSN: 0888-5885            Impact factor:   3.720


  33 in total

Review 1.  Hydrogels for oral delivery of therapeutic proteins.

Authors:  Nicholas A Peppas; Kristy M Wood; James O Blanchette
Journal:  Expert Opin Biol Ther       Date:  2004-06       Impact factor: 4.388

2.  Novel approach to Gorlin syndrome: a patient treated with oral capecitabine.

Authors:  Douglas F Beach; Robert Somer
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

3.  Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.

Authors:  E Van Cutsem; C Twelves; J Cassidy; D Allman; E Bajetta; M Boyer; R Bugat; M Findlay; S Frings; M Jahn; J McKendrick; B Osterwalder; G Perez-Manga; R Rosso; P Rougier; W H Schmiegel; J F Seitz; P Thompson; J M Vieitez; C Weitzel; P Harper
Journal:  J Clin Oncol       Date:  2001-11-01       Impact factor: 44.544

4.  Advanced molecular design of biopolymers for transmucosal and intracellular delivery of chemotherapeutic agents and biological therapeutics.

Authors:  William B Liechty; Mary Caldorera-Moore; Margaret A Phillips; Cody Schoener; Nicholas A Peppas
Journal:  J Control Release       Date:  2011-06-14       Impact factor: 9.776

5.  Patient preferences for oral versus intravenous palliative chemotherapy.

Authors:  G Liu; E Franssen; M I Fitch; E Warner
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

6.  Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(L-histidine-)-poly(L-lactide) nanoparticles.

Authors:  Rong Liu; Dong Li; Bin He; Xianghui Xu; Mingming Sheng; Yusi Lai; Gang Wang; Zhongwei Gu
Journal:  J Control Release       Date:  2011-03-22       Impact factor: 9.776

7.  Novel oral colon-specific drug delivery systems for pharmacotherapy of peptide and nonpeptide drugs.

Authors:  S M Reddy; V R Sinha; D S Reddy
Journal:  Drugs Today (Barc)       Date:  1999-07       Impact factor: 2.245

8.  Complexation hydrogels for intestinal delivery of interferon beta and calcitonin.

Authors:  Noriyasu Kamei; Mariko Morishita; Hitomi Chiba; Nikhil J Kavimandan; Nicholas A Peppas; Kozo Takayama
Journal:  J Control Release       Date:  2008-11-27       Impact factor: 9.776

9.  Polyvinyl alcohol-poly(caprolactone) semi IPN scaffold with implication for cartilage tissue engineering.

Authors:  Neethu Mohan; Prabha D Nair
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2008-02       Impact factor: 3.368

10.  Antithrombogenicity of hydrophilic polyurethane-hydrophobic polystyrene IPNs. II. In vitro and ex vivo studies.

Authors:  Y C Shin; D K Han; Y H Kim; S C Kim
Journal:  J Biomater Sci Polym Ed       Date:  1994       Impact factor: 3.517

View more
  7 in total

1.  Intelligent recognitive systems in nanomedicine.

Authors:  Heidi Culver; Adam Daily; Ali Khademhosseini; Nicholas Peppas
Journal:  Curr Opin Chem Eng       Date:  2014-05-01       Impact factor: 5.163

2.  Hybrid responsive hydrogel carriers for oral delivery of low molecular weight therapeutic agents.

Authors:  M Caldorera-Moore; K Maass; R Hegab; G Fletcher; N Peppas
Journal:  J Drug Deliv Sci Technol       Date:  2015-12-01       Impact factor: 3.981

3.  pH-responsive hydrogels with dispersed hydrophobic nanoparticles for the oral delivery of chemotherapeutics.

Authors:  Cody A Schoener; Heather N Hutson; Nicholas A Peppas
Journal:  J Biomed Mater Res A       Date:  2012-12-28       Impact factor: 4.396

4.  pH-responsive hydrogels containing PMMA nanoparticles: an analysis of controlled release of a chemotherapeutic conjugate and transport properties.

Authors:  Cody A Schoener; Nicholas A Peppas
Journal:  J Biomater Sci Polym Ed       Date:  2012-10-15       Impact factor: 3.517

5.  pH-Responsive Hydrogels with Dispersed Hydrophobic Nanoparticles for the Delivery of Hydrophobic Therapeutic Agents.

Authors:  Cody A Schoener; Heather N Hutson; Nicholas A Peppas
Journal:  Polym Int       Date:  2012-04-11       Impact factor: 2.990

Review 6.  Hydrogels for Hydrophobic Drug Delivery. Classification, Synthesis and Applications.

Authors:  Eneko Larrañeta; Sarah Stewart; Michael Ervine; Rehan Al-Kasasbeh; Ryan F Donnelly
Journal:  J Funct Biomater       Date:  2018-01-24

Review 7.  Re-evaluating the importance of carbohydrates as regenerative biomaterials.

Authors:  Heidi F Oldenkamp; Julia E Vela Ramirez; Nicholas A Peppas
Journal:  Regen Biomater       Date:  2018-11-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.